0001415889-24-012328.txt : 20240506
0001415889-24-012328.hdr.sgml : 20240506
20240506163013
ACCESSION NUMBER: 0001415889-24-012328
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240503
FILED AS OF DATE: 20240506
DATE AS OF CHANGE: 20240506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SULLIVAN LOUIS W
CENTRAL INDEX KEY: 0001193522
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 24917984
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN LOUIS
DATE OF NAME CHANGE: 20020927
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1000 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4-05062024_040501.xml
X0508
4
2024-05-03
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001193522
SULLIVAN LOUIS W
C/O UNITED THERAPEUTICS CORPORATION
1000 SPRING STREET
SILVER SPRING
MD
20910
true
false
false
false
0
Common Stock
2024-05-03
4
M
0
5160
119.76
A
18220
D
Common Stock
2024-05-03
4
S
0
2181
257.3895
D
16039
D
Common Stock
2024-05-03
4
S
0
2979
259.1199
D
13060
D
Stock Options
119.76
2024-05-03
4
M
0
5160
0
D
2021-06-26
2030-06-26
Common Stock
5160
0
D
This transaction was executed in multiple trades at prices ranging from $256.98 to $257.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $258.49 to $259.395. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ John S. Hess, Jr. under Power of Attorney
2024-05-06